Amanda Johnson, MD
@amjohnsonmd
Gastroenterologist at @MayoClinicGIHep with clinical and research interests in #IBD and #obesity. Tweets are my own.
ID: 900884880304861185
25-08-2017 00:57:47
225 Tweet
962 Followers
187 Following
Reviewing the impact of obesity on #IBD and considerations for optimizing management : Current Opinion in Gastroenterology journals.lww.com/co-gastroenter… Wissam Ghusn Amanda Johnson, MD
Family in more ways than one #DDW2024 Adam Bledsoe, MD LL John Kisiel Victor Chedid, MD Amanda Johnson, MD Gui Ramos MD S Loftus Beth Loftus Vivek Tharayil
#DDW2024 researcher Andres Acosta found that a machine-learning genetic algorithm — the “hungry gut” phenotype test — can predict which patients will do best on semaglutide weight-loss drugs American Gastroenterological Association (AGA)
Intriguing talk from Florian Rieder on creeping fat (CF) and CD stricturing ✅CF persists following endoscopic remission, and is immunologically active ✅CF assoc w/ smooth muscle proliferation/stricturing ✅degree CF on CTE correlates with intestinal fibrotic stricturing
So proud of @PennGIHep & @milestoneibd fellow Priya Sehgal at podium to standing-room-only talk on our work looking at safety & efficacy of GLP-1 agonists in #IBD. Experience same as gen pop; no safety concerns, similar side effects, ⬇️ CRP & effective weight loss.
The positive spin is maybe for our surgical colleagues to routinely follow this protocol to improve surgical results for perianal disease. Still a huge unmet need for our patients. #DDW2024 Anthony de Buck Mantaj Brar
The #REBOOTIBD group (minus a few) with our poster on RWE of risankizumab in Crohns Manar Askar Parakkal Deepak MD, MS, FACG Ryan Ungaro MD MS Shrinivas Bishu Andres Yarur Richa Shukla Jalpa Devi
Do you want to know real-world effectiveness & safety of Upadacitinib in CD? check Jalpa Devi at #1882. #DDW2024 @WUGastro Amanda Johnson, MD Parakkal Deepak MD, MS, FACG Mayo Clinic Gastroenterology & Hepatology
Risankizumab for Ulcerative Colitis jamanetwork.com/journals/jama/… JAMA Remo Panaccione, MD, FRCPC Jean-Frederic Colombel
IT IS ALIVE American Gastroenterological Association (AGA) #UlcerativeColitis Berkeley Limketkai @ManasiAgrawalMD John Haydek, MD MS Ashwin,M.D Frank I Scott, MD MSCE
Keynote from Andres Yarur on metabolic implications in IBD ⏭️ MASLD is common in IBD, even without usual risk factors ⏭️ Prevalence of obesity in IBD is rising ⏭️ Visceral adiposity may have implications on response to biologic therapy #AIBD24
Interesting paradigm of adding GLP1RAs in patients with #IBD with positive clinical outcomes reported from multiple centers, whether impact on VAT compartment &/or epithelial healing, to be studied in upcoming trial funded Helmsley Charitable Trust led by #LouisCohen myself & Andres Yarur
Another clinically useful RWE data output from #REBOOTIBD consortium led Amanda Johnson, MD Mayo Clinic Gastroenterology & Hepatology Longer tweet to follow on data! Multicenter Study of the Real-World Effectiveness and Safety of Risankizumab in Crohn’s Disease Journal of Crohn's and Colitis Y-ECCO academic.oup.com/ecco-jcc/artic…
Patients with Crohn’s Disease and Ileostomy Can Respond to Upadacitinib | Digestive Diseases and Sciences Lauren Loeb, MD Jami Kinnucan, MD, FACG, AGAF, FCCF Jami Kinnucan, MD, FACG, AGAF, FCCF Jana G Hashash, MD, MSc Francis (Frank) Farraye, MD, MSc link.springer.com/article/10.100…